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Summary
Autosomal dominant facioscapulohumeral muscular
dystrophy (FSHD) is caused by deletion of most copies
of the 3.3-kb subtelomeric D4Z4 repeat array on chro-
mosome 4q. The molecular mechanisms behind the de-
letion and the high proportion of new mutations have
remained elusive. We surveyed 35 de novo FSHD fam-
ilies and found somatic mosaicism in 40% of cases, in
either the patient or an asymptomatic parent. Mosaic
males were typically affected; mosaic females were more
often the unaffected parent of a nonmosaic de novo pa-
tient. A genotypic-severity score, composed of the resid-
ual repeat size and the degree of somatic mosaicism,
yields a consistent relationship with severity and age at
onset of disease. Mosaic females had a higher proportion
of somatic mosaicism than did mosaic males. The repeat
deletion is significantly enhanced by supernumerary ho-
mologous repeat arrays. In 10% of normal chromo-
somes, 4-type repeat arrays are present on chromosome
10. In mosaic individuals, 4-type repeats on chromo-
some 10 are almost five times more frequent. The reverse
configuration, also 10% in normal chromosomes, was
not found, indicating that mutations may arise from
transchromosomal interaction, to which the increase in
4-type repeat clusters is a predisposing factor. The so-
matic mosaicism suggests a mainly mitotic origin; mi-
totic interchromosomal gene conversion or translocation
between fully homologous 4-type repeat arrays may be
a major mechanism for FSHD mutations.
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Introduction
Facioscapulohumeral muscular dystrophy (FSHD [MIM
158900]) is a neuromuscular disorder with an autosomal
dominant pattern of inheritance. Clinically, the disease
is characterized mainly by a progressive wasting of the
facial, shoulder, and upper-arm muscles, and it displays
substantial inter- and intrafamilial variation. FSHD has
an incidence of 1/20,000 in the European population,
and there is a relatively high proportion of new muta-
tions (10%–30%) (Padberg 1982; Padberg et al. 1995;
Zatz et al. 1995, 1998; Tawil et al. 1996; Lunt 1998).
All patients with a confirmed diagnosis and for whom
detailed molecular studies have been performed carry a
chromosomal rearrangement within the subtelomere of
chromosome 4q (4q35). This subtelomere is composed
mainly of a polymorphic repeat structure consisting of
3.3-kb repeated elements (D4Z4). The number of repeat
units varies from 10 to 1100 in the population, and, in
FSHD patients, an allele of 1–10 residual units is ob-
served because of the deletion of an integral number of
these units (Wijmenga et al. 1992; van Deutekom et al.
1993).
A highly homologous polymorphic repeat array is lo-
cated near the telomere of chromosome 10q (Bakker et
al. 1995; Deidda et al. 1995), and a specific BlnI site
within each chromosome 10–derived repeat unit allows
discrimination between the arrays (Deidda et al. 1996).
This BlnI site–dependent discrimination demonstrated
the presence of 10-type repeats on chromosome 4 and,
vice versa, 4-type repeats on chromosome 10, suggesting
a dynamic exchange between these chromosomes. Of the
50 healthy control males studied, 5 : 100 chromosomes
carried a 4-type repeat on chromosome 10, and 5 : 100
chromosomes carried a 10-type repeat on chromosome
4 (fig. 1) (van Deutekom et al. 1996). Hybrid repeat
arrays consisting of clusters of both 4-type and 10-type
repeat units are also found. Only short repeat arrays on
chromosome 4 cause FSHD, irrespective of the type of
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Figure 1 Subtelomeric repeat-array constitutions on chromo-
somes 4 and 10 in the Dutch control and FSHD population. Chro-
mosomes 4 are shaded, whereas chromosomes 10 are blackened. Top,
in the control population, 80% of the individuals carry a standard
configuration, with 4-type repeats on chromosome 4 and 10-type re-
peats on chromosome 10. In 10%, a 4-type repeat is also present on
one of the chromosomes 10 (“4 on 10”), and 10% carry a 10-type
repeat on chromosome 4 (“10 on 4”). Bottom, the repeat-array con-
stitutions of mosaic individuals from de novo FSHD families. The
deletion is indicated by an open bar. These individuals carry two cell
populations indicated within a box. In the original population, no
FSHD-associated rearrangement is present, whereas, in the other pop-
ulation, a deletion has occurred on chromosome 4. In mosaic individ-
uals, 54% carry a standard allele configuration, and 46% carry a “4
on 10” allele configuration.
repeat units. Small repeat arrays on chromosome 10 are
nonpathogenic (Cacurri et al. 1998; Lemmers et al.
1998).
To understand the molecular basis of FSHD, the re-
peat array and adjacent regions have been scrutinized
for expressed sequences (Hewitt et al. 1994; Lee et al.
1995). Also, the severity and age at onset of the disease
have been correlated with the size of the residual repeat
array on chromosome 4 (Lunt et al. 1995; Tawil et al.
1996). However, this has not yet clarified the genetic
mechanisms underlying the deletion event, nor have the
relatively high mutation frequency and the inter- and
intrafamilial variation in clinical expression of the dis-
ease been explained. To elucidate the deletion process
and the clinical variability of the disease, we have fo-
cused our attention on the repeat constitutions of de
novo patients and their parents. The high degree of so-
matic mosaicism described here implies that the deletion
is mainly mitotic. Furthermore, we find a distinct and
as yet unexplained relationship between sex and affec-
tion status in mosaic carriers. Finally, we find that the
numerical excess of 4-type repeats on chromosome 10
is a significant if not the major predisposing factor for
the occurrence of the FSHD-type deletion.
Subjects and Methods
Patients and Controls
After informed consent, DNA isolated from peripheral
blood lymphocytes (PBLs) of 35 sporadic FSHD patients
and their parents were obtained via one of the Dutch
Neuromuscular Centers. All patients had clinical diag-
noses of FSHD. In all cases, diagnosis was confirmed by
the presence of a short (!35 kb) D4Z4-repeat array. The
repeat-array constitutions of 50 healthy control males
has been described elsewhere (van Deutekom et al.
1996).
Clinical manifestations.—The age at onset of the var-
ious stages of FSHD was established in 12 mosaic in-
dividuals. Clinical severity scores were based on the age
at onset of the initial clinical symptoms: 0 (no signs, no
symptoms), 1 (facial weakness, no symptoms), 2 (onset
of symptoms at age 20 years), 3 (onset of symptoms
at age 15–19 years), 4 (onset of symptoms at age 10–14
years), and 5 (onset of symptoms at age !10 years).
PFGE.—Five micrograms of DNA was double digested
with EcoRI/HindIII (E/H) or double digested by EcoRI/
BlnI (E/B) according to the manufacturer’s instructions.
DNA was separated by PFGE. In brief, DNA was loaded
on a 0.8% agarose gel (Boehringer MP agarose) in
and separated by PFGE for 20 h at 8.5 V/0.5# TBE
cm (van Deutekom et al. 1996). After blotting to a Ny-
tran membrane (Schleicher & Schuell), the DNA was
hybridized sequentially with p13E-11 (D4F104S1) and
9B6A (D4Z4) (Wijmenga et al. 1992) as described else-
where (Lemmers et al. 1998). After exposure to phos-
phorimager screens, repeat arrays were assigned to their
chromosomal location on the basis of their BlnI sensi-
tivity. Somatic mosaicism was defined as a fifth fragment
hybridizing with p13E-11 in one individual. The pro-
portion of cells carrying the mosaic alleles was estimated
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Table 1
Repeat-Array Constitution of 35 Dutch De Novo FSHD Families
FAMILY
D4Z4 REPEAT
LENGTH
(UNITS) SEX
COMPLETE
ALLELE
INFORMATION
PRESENCE OF MOSAICISM IN
INHERITANCE
ALLELE
CONSTITUTION
IN MOSAIC
INDIVIDUALSFather Mother Patient
1 2 M   4 on 10
2 5 M Maternal
3 4 M Paternal
4 2 F  Paternal Standard
5 2 M  Standard
6 1 M   4 on 10a
7 4 M  Standard
8 3 M  Paternal
9 1 M   Maternal 4 on 10b
10 3 F  Maternal
11 5 M   Maternal Standard
12 4 F   4 on 10
13 4 F  Standard
14 4 F Maternal
15 3 F ?
16 4 F ?
17 6 F ?
18 3 F  Maternal
19 4 F  Maternal
20 4 F  Maternal
21 4 M  Paternal
22 3 M  ?
23c 3 M  Paternal
24 3 M   Standard
25 4 F  Maternal
26 2 M   Standard
27 4 F  ?
28 6 F  Paternal
29 3 M  Maternal
30 2 M  Paternal
31 6 F  Maternal
32 2 F  Paternal
33 4 M  Maternal
34 4/5d M   Paternal 4 on 10
35 2/6d M 
NOTE.—A plus sign () indicates presence, and a question mark (?) indicates unknown.
a This individual carries a hybrid allele on chromosome 10, consisting of both 4-type and 10-type repeat units.
b This individual carries only 4-type repeat arrays (fig. 3B).
c In this patient, the partial deletion of the D4Z4 repeat arrays includes the p13E-11 region.
d These individuals are mosaic for two short repeat arrays.
by comparison of the observed signal intensity with the
expected intensity. Signal intensities of the various hy-
bridizing fragments were obtained with the IMAGE-
QUANT program (Molecular Dynamics).
Statistical evaluation.—The allele constitutions in mo-
saic and control individuals were evaluated according to
Fisher’s exact test. D4Z4 repeat–array lengths in mosaic
and control individuals were compared by means of the
Mann-Whitney U test (one sided).
A relationship between the age at onset and the pro-
portion of cells carrying the deleted allele was calculated
by linear regression analysis. For this purpose, we con-
structed a composite genotypic-severity scale: (5
fraction ofremaining number of repeat units)# the
cells showing that deletion. The number 5 is the largest
repeat array observed in mosaic individuals in this study.
Results
Allele Identification by PFGE
The repeat-array constitutions of 35 Dutch sporadic
FSHD patients (19 males and 16 females) and their par-
ents were analyzed by PFGE (table 1). For all but two
patients, DNA from the parents was studied. In 23 fam-
van der Maarel et al.: Somatic Mosaicism in FSHD 29
Table 2
Repeat Allele Information for the 35 FSHD Families Studied
Type of FSHD and Characteristic
No. of
Individuals
Familial (n = 1) 1
De novo (n = 34): 34
Mosaicism: 14a
Male carriers 2
Female carriers 3
Male affecteds 7
Female affecteds 2
Repeat-array constitution in mosaic individuals:a
Standard 7
4 on 10 6
10 on 4 0
a Thirteen individuals with complete information on all alleles.
ilies we could determine the chromosomal origin and
the size of each of the four repeat arrays (on chromo-
somes 4 and 10) in both patients and parents. In the 10
remaining families with incomplete information, the
DNA quality of one of the individuals was not sufficient
to assign all alleles.
All patients showed one BlnI-insensitive repeat array
!35 kb (9 units), consistent with FSHD diagnosis (Bak-
ker et al. 1996; Lunt 1998) (table 1). The lengths of
these arrays varied from 8 kb (1 unit and flanking se-
quences) to 25 kb (6 units). One patient inherited a 6-
unit repeat array from his clinically unaffected father.
Mosaicism
We observed 14 cases of somatic mosaicism (defined
by a fifth band on PFGE; tables 1 and 2 and fig. 1). In
3 of the 23 fully informative families, we observed mo-
saicism for the disease allele in unaffected parents (2
mothers and 1 father), and in 5 more families the patients
were mosaic (4 males and 1 female; tables 2 and 3). In
the remaining 12 families, for which we did not have
full information on all repeat lengths, we observed mo-
saicism in one father, one mother, and four patients
(three males and one female; tables 2 and 3).
The IMAGEQUANT program was used to estimate
the percentage of the cell population carrying the deleted
allele in mosaic individuals; this varied from 15% to
95% (table 3). Where possible, the parental origin of
the mosaic allele was determined, as well as the original
repeat-array size and the size of the deletion (table 3).
In 8/11 mosaic individuals, the smallest D4Z4 allele was
reduced to an FSHD-sized repeat array. A genotypic-
severity score composed of the size of the residual repeat
array and the proportion of cells carrying this array
could be established in 11 mosaic individuals (table 3).
The age at onset of the clinical manifestations was
used for a clinical severity score for the mosaic individ-
uals (table 3). A relationship could be established be-
tween the age at onset of the disease, on the one hand,
and the fraction of cells carrying the deleted allele and
the residual repeat-array length (fig. 2), on the other
hand. Individuals with a large proportion of cells car-
rying the disease allele have an earlier age at onset of
the disease ( ).P ≈ .02
Repeat-Array Inheritance
To determine whether the presence of either 4-type
repeat arrays on chromosome 10 or 10-type repeat ar-
rays on chromosome 4 might play a role in the deletion
mechanism, we analyzed the repeat-array constitutions
in those mosaic individuals in which we could score all
alleles (13/14). Of these 13, 6 carried one or more 4-
type repeat arrays on chromosome 10 (fig. 1 and table
3). Typically, in these cases, PFGE analysis revealed the
presence of five p13E-11 hybridizing fragments: three
BlnI-insensitive (4-type) repeat arrays 135 kb; one BlnI-
sensitive (10-type) repeat array; and the mosaic, trun-
cated, disease- associated repeat array !35 kb (fig. 1 and
3A and table 2). In one of these six individuals, the
“nonstandard” repeat array consisted of both 4-type and
10-type repeat units (data not shown). One mosaic in-
dividual even carried only 4-type repeat arrays (fig. 3B).
According to the results of Fisher’s exact test, the fre-
quency of 4-type repeats on chromosome 10 in the mo-
saic individuals (6 [40%] of 13) differs significantly from
the Dutch control population, previously determined at
10% (van Deutekom et al. 1996) ( ). In con-P = .0125
trast, 0/13 mosaic individuals showed the reverse con-
figuration of three or more BlnI-sensitive arrays indic-
ative of the presence of 10-type repeat units on
chromosome 4.
Discussion
Although the deletion of an integral proportion of
D4Z4 repeat arrays has been well established as the
causal mutation of FSHD, little is known about the
mechanism by which the deletion arises. We recently
found that highly homologous repeat units on chro-
mosomes 4 and 10 may interact, resulting in exchanged
repeat units on both chromosomes in 20% of the pop-
ulation (van Deutekom et al. 1996; Lemmers et al.
1998). Recently, we could confirm this finding in a larger
sample of both males and females (van der Maarel, un-
published data). To obtain more insight into the deletion
mechanism and the putative role of interchromosomal
repeat interference, we studied the repeat-array consti-
tution on chromosomes 4 and 10 in 35 de novo FSHD
families ascertained via the Dutch neuromuscular cen-
ters. The results highlight several aspects of FSHD, not
previously reported, that are relevant to the basic and
clinical insight in FSHD etiology.
Ta
bl
e
3
M
os
ai
c
In
di
vi
du
al
s
in
D
e
N
ov
o
FS
H
D
Fa
m
ili
es
FA
M
IL
Y
SE
X
R
E
P
E
A
T
L
E
N
G
T
H
A
F
F
E
C
T
IO
N
ST
A
T
U
S
PE
R
C
E
N
T
A
G
E
O
F
PB
L
S
C
A
R
R
Y
IN
G
A
L
L
E
L
E
(S
IZ
E
,
IN
K
B
)
IN
H
E
R
IT
A
N
C
E
R
E
A
R
R
A
N
G
E
D
A
L
L
E
L
E
a
D
b
(k
b)
A
L
L
E
L
E
C
O
N
ST
IT
U
T
IO
N
A
G
E
(I
N
Y
E
A
R
S)
A
T
O
N
SE
T
O
F
W
E
A
K
N
E
SS
c
SE
V
E
R
IT
Y
SC
O
R
E
O
ri
gi
na
l
D
is
ea
se
Sh
ou
ld
er
Fo
ot
E
xt
en
so
r
Pe
lv
ic
C
lin
ic
al
G
en
ot
yp
ic
1
M
2
A
ff
ec
te
d
50
(7
0)
50
(1
2)
Pa
te
rn
al
Sm
al
l
58
4
on
10
15
19
40
3
1.
50
5
M
2
A
ff
ec
te
d
80
(9
6)
20
(1
2)
Pa
te
rn
al
Sm
al
l
84
St
an
da
rd
18
23

3
.6
0
6
M
1
A
ff
ec
te
d
66
(2
30
)
34
(8
)
Pa
te
rn
al
L
ar
ge
22
2
4
on
10
4
4
4
5
1.
36
7
M
4
A
ff
ec
te
d
73
(6
5)
27
(1
8)
M
at
er
na
l
Sm
al
l
47
St
an
da
rd
18
?
34
3
.2
7
12
F
4
A
ff
ec
te
d
5
(8
0)
95
(1
8)
M
at
er
na
l
L
ar
ge
62
4
on
10
12
7
12
5
.9
5
13
F
4
A
ff
ec
te
d
35
(6
2)
65
(1
7)
?
Sm
al
l
45
St
an
da
rd
14
?
?
4
.6
5
24
M
3
A
ff
ec
te
d
55
(4
0)
45
(1
5)
M
at
er
na
l
Sm
al
l
25
St
an
da
rd
14
30
30
4
.9
0
26
M
2
A
ff
ec
te
d
60
(1
30
)
40
(1
2)
M
at
er
na
l
L
ar
ge
11
8
St
an
da
rd
13
11
18
4
1.
20
35
M
2/
6
A
ff
ec
te
d
4
on
10
73
48
72
2
4
M
2
C
ar
ri
er
67
(4
0)
33
(1
2)
Sm
al
l
28
St
an
da
rd
?
?
?
34
M
4/
5
C
ar
ri
er
60
(2
2)
40
(1
9)
Sm
al
l
3
4
on
10



0
.0
0
9
F
1
C
ar
ri
er
85
(1
10
)
15
(1
0)
10
0
4
on
bo
th
10

d


1
.6
0
10
F
3
C
ar
ri
er
?
?
?
11
F
4
C
ar
ri
er
62
(4
8)
38
(2
1)
Sm
al
l
27
St
an
da
rd



0
.3
8
a
Sm
al
le
st
or
la
rg
es
t
ch
ro
m
os
om
e
4
al
le
le
re
ar
ra
ng
ed
.
b
Si
ze
of
th
e
de
le
ti
on
.
c
A
m
in
us
si
gn
(
)
in
di
ca
te
s
th
at
th
e
in
di
vi
du
al
is
no
t
af
fe
ct
ed
;
a
qu
es
ti
on
m
ar
k
(?
)
in
di
ca
te
s
on
se
t
un
kn
ow
n.
d
T
hi
s
in
di
vi
du
al
ha
s
a
m
ild
fa
ci
al
w
ea
kn
es
s.
van der Maarel et al.: Somatic Mosaicism in FSHD 31
Figure 2 Relationship between clinical and genotypic severity
in mosaic individuals. The clinical severity is on the Y axis, whereas
the genotypic severity, calculated by [(5 number of remaining repeat
units) # fraction of cells with that deletion] is on the X axis. Males
are represented by blackened squares, whereas females are represented
by blackened circles.
Mitosis or Meiosis
We identified somatic mosaicism in 40% of our de
novo families. Mosaicism has previously been reported
for several human X-linked and autosomal dominant
diseases, including Duchenne muscular dystrophy and
hemophilia A (Bakker et al. 1987; Passos-Bueno et al.
1992; Becker et al. 1996). Also, for several tumor-prone
syndromes, such as neurofibromatosis type 2 and reti-
noblastoma, mosaicism has been reported (Evans et al.
1998; Sippel et al. 1998). However, the high proportion
of mosaicism identified in FSHD, as reported here, is
unprecedented. Considering that we had full allele in-
formation on only 23/35 de novo families and that PFGE
reveals only a significant degree of mosaicism, we esti-
mate that 40%, and possibly much more, of de novo
families carry somatic mosaicism for the disease allele.
Therefore, we propose that the FSHD rearrangement is
predominantly mitotic.
Interchromosomal Repeat Interference
In 6 (46%) of 13 of the mosaic individuals in whom
we could score all alleles, we observed one or more 4-
type repeat arrays on chromosome 10. In the Dutch
population, this type of repeat-array configuration is
present in only 10% of the individuals (van Deutekom
et al. 1996). The reverse configuration, equally present
in 10% of controls, was never found in association with
mosaicism. This provides strong support for the causal
involvement of the extra 4-type repeat in the partial
deletion of one of them and, in the case of chromosome
4, leading to FSHD. Studies of minisatellite repeat struc-
tures and a similar megasatellite repeat (RNU2) in the
human genome indicate that intrachromosomal recom-
bination, such as unequal sister-chromatid exchange
(USCE) or intrachromatid gene conversion, dominates
over interchromosomal recombination processes (Jef-
freys et al. 1994; Liao et al. 1997). A high rate of in-
trachromosomal recombination effects homogenization
and hence concerted evolution of repetitive multigene
families, which is thought to maintain the integrity of
each repeated gene (Liao 1999). In FSHD, a similar pro-
cess might well play a role in the partial deletion of the
D4Z4 repeat–array rearrangements. Since USCE should
result in a reciprocal allele in the mosaics, which we
have never observed, these deletions may arise by gene
conversion.
On the other hand, the numerical excess of 4-type
repeats on chromosome 10 in mosaic individuals indi-
cates that supernumerary 4-type repeats may physically
facilitate the partial deletion on either chromosome 4 or
chromosome 10 (which would go undetected). In this
model, the deletion arises independent of its inter- or
intrachromosomal nature. Since recombination depends
highly on the homology between both alleles (Lambert
et al. 1999), normal 10-type repeat units may have di-
verged sufficiently to suppress their contribution to
D4Z4 repeat deletions. For rDNA repeat arrays, recom-
bination between nonhomologous chromosomes has
been reported and was attributed to the close proximity
of these repeat alleles in the nucleolus (Arnheim et al.
1980).
Allele Sizes
In most of the mosaic individuals, the original allele
from which the disease allele has arisen could be iden-
tified by the lower hybridization intensity. Strikingly, in
most of the cases (8/11), it was the shortest D4Z4 repeat
allele that was reduced to an FSHD-sized repeat array.
This finding may be due to ascertainment bias wherein
mosaicism of relatively large alleles remains unnoticed,
since they will not be reduced to arrays smaller than 35
kb. Indeed, the size distribution of the original alleles
was significantly smaller than the size distribution of 78
standard chromosome 4 alleles in the control population
( ). This may indicate that deletions from rela-P ! .05
tively large alleles may in general have no pathological
consequences.
As already observed by Zatz et al. (1998), the FSHD
allele in asymptomatic mosaic individuals is relatively
short. The average repeat length in mosaic individuals
in this study is 3.1 units, whereas nonmosaic patients
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Figure 3 A, Somatic mosaicism in a de novo FSHD patient (FSHD1). DNA, digested by EcoRI/HindIII (H) or EcoRI/BlnI (B) and separated
by PFGE, was visualized with probe p13E-11. The patient inherited a 65-kb 4-type repeat array from his father, which is reduced in 50% of
his PBLs to the FSHD range of 10 kb (both alleles have a reduced intensity [arrows]). Note that this patient inherited from his mother two 4-
type repeat arrays and, therefore, has a 4 on 10 repeat-array configuration. Y alleles are marked with an asterisk (*). The son of this patient
inherited both grandmaternal alleles and is therefore not affected. B, Somatic mosaicism in a female carrier of a de novo FSHD kindred (FSHD9).
DNA, digested by EcoRI/HindIII (H) or EcoRI/BlnI (B) and separated by PFGE, was visualized with probe p13E-11. The patient carries a short
BlnI-insensitive repeat array of 10 kb (arrow), indicating FSHD. This allele (arrow) is also weakly present in the mother, who carries on
chromosomes 4 and 10 four-type repeat arrays, identified on the basis of their BlnI insensitivity. The Y chromosomal cohybridizing fragment
is marked with an asterisk (*).
carry, on average, 3.9 units. This may be explained in
part by the association between the residual repeat size
and severity and age at onset of the disease. In general,
small alleles result in a more severe phenotype (Lunt et
al. 1995; Tawil et al. 1996), and it may well be that, in
mosaic individuals, the tolerance for short alleles is
smaller than that for larger FSHD alleles. In this sce-
nario, high proportions of cells carrying larger FSHD
alleles may be required, to elicit a disease phenotype.
The resulting low proportion of original alleles may go
undetected by PFGE.
Alternatively, in addition to the mosaic rearrangement
described here, which exhibits relatively short arrays, an
unidentified mutational mechanism may exist that re-
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sults in relatively larger FSHD arrays. If such an alter-
native exists, the high proportion of severely affected
patients among de novo cases may be explained by a
mechanistic difference rather than by a clinical ascer-
tainment bias.
Sex and Affection Status
Somatic mosaicism has been observed in 15%–20%
of the unaffected parents of de novo FSHD patients. In
these studies, a female predominance of mosaic carriers
(15 females : 6 males) was reported and was then at-
tributed to a higher mutation rate in females than in
males (Kohler et al. 1996; Lunt 1998; Zatz et al. 1998).
In agreement, we found parental mosaicism in 14% of
our de novo families (three females and two males).
In addition to mosaicism in parents, we found a high
frequency (26%) of somatic mosaicism in de novo FSHD
patients who belong to different families as the mosaic
carrier parents. In these mosaic patients we find, in con-
trast, an excess of mosaic males over mosaic females (7
: 2). The proportion of cells carrying the deletion allele
varied from 15% to 95% on the basis of the signal
intensities of the different alleles. Typically, in mosaic
female patients, the proportion of the deleted allele was
higher than in mosaic male patients (table 3). Combining
the female excess among unaffected mosaic carrier par-
ents with the male mosaic excess among the patients
themselves, we propose that the female predominance
of mosaic asymptomatic carriers is not due to a higher
mutation rate in females, but rather to a higher clinical
tolerance for mosaic disease alleles in females compared
with males. Consistent with this proposal, males are
more severely affected than females (Padberg 1982; Lunt
et al. 1989; Padberg et al. 1995; Zatz et al. 1998).
Although the extent of somatic mosaicism depends on
the timing of the deletion event and on tissue-specific
selection, we established a relationship between the re-
sidual repeat size and the proportion of cells carrying
this disease allele, on one hand, and the severity and age
at onset on the other ( ). This suggests that theP ≈ .02
mutation may already occur early in embryogenesis, be-
fore the divergence of muscle and lymphocyte lineages.
Nevertheless, it will be important to analyze the mo-
saicism in muscles of mosaic patients and parents.
Implications for FSHD Diagnosis
For autosomal dominant diseases, recurrence risks in
parents of de novo patients are considered very low,
whereas disease carriers have 50% probability of having
affected offspring. Since we have detected somatic mo-
saicism in 40% of the de novo families, this is not
necessarily true for de novo FSHD families. According
to table 3, since asymptomatic mosaic carriers may have
as much as 40% of cells carrying the disease allele, such
carriers may have a 20% risk that their offspring will
be affected. In contrast, the mosaic FSHD patient in
family 5 may have as little as 10% risk of having affected
offspring. Detailed analysis of somatic and germline mo-
saicism in de novo FSHD families will be required, to
obtain more-accurate figures for genetic counseling.
In conclusion, we have shown (1) that the D4Z4 re-
peat reduction associated with FSHD arises in ∼40% of
the de novo cases, mitotically, in either parent or patient;
(2) that the basic mechanism of the repeat reduction
likely involves inter- or, possibly, intrachromosomal gene
conversion; (3) that this is facilitated by the presence of
D4Z4 repeat arrays on chromosome 10, which thus pre-
disposes for the deletion; (4) that somatic mosaicism
occurs in both males and females but that males are more
often affected than females; therefore, the proposed sex
difference in the occurrence of somatic mosaicism may
in fact be a sex-dependent clinical threshold for the mo-
saic disease allele; and (5) that a relationship exists be-
tween, on one hand, a combination of the residual repeat
size and proportion of cells carrying the disease allele
and, on the other hand, the age at onset and the severity
of the disease. This chromosomal copy number–
dependent repeat interference may well turn out to be
a basic mechanism for genome instability involving mul-
ticopy repetitive elements.
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